These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 18237792)

  • 1. NT-pro-BNP for differential diagnosis in patients with syncope.
    Pfister R; Diedrichs H; Larbig R; Erdmann E; Schneider CA
    Int J Cardiol; 2009 Mar; 133(1):51-4. PubMed ID: 18237792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NT-pro-BNP for differential diagnosis in patients with syncope.
    Costantino G; Solbiati M; Pisano G; Furlan R
    Int J Cardiol; 2009 Nov; 137(3):298-9; author reply 299. PubMed ID: 18691777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT-pro-BNP for diagnostic and prognostic evaluation in patients hospitalized for syncope.
    Pfister R; Hagemeister J; Esser S; Hellmich M; Erdmann E; Schneider CA
    Int J Cardiol; 2012 Mar; 155(2):268-72. PubMed ID: 21056483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictive value of NT-pro-BNP for the non-cardiologist. A study on 573 hospitalized patients with cardiovascular disease].
    Pfister R; Tan D; Thekkanal J; Erdmann E; Schneider CA
    Dtsch Med Wochenschr; 2008 Mar; 133(12):564-9. PubMed ID: 18335382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study).
    O'Donoghue M; Kenney P; Oestreicher E; Anwaruddin S; Baggish AL; Krauser DG; Chen A; Tung R; Cameron R; Januzzi JL
    Am J Cardiol; 2007 Nov; 100(9):1336-40. PubMed ID: 17950786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].
    El Mahmoud R; Alibay Y; Brun-Ney D; Boulard JC; Dubourg O; Puy H; Jondeau G
    Arch Mal Coeur Vaiss; 2006 Mar; 99(3):201-7. PubMed ID: 16618022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery.
    Goei D; Schouten O; Boersma E; Welten GM; Dunkelgrun M; Lindemans J; van Gestel YR; Hoeks SE; Bax JJ; Poldermans D
    Am J Cardiol; 2008 Jan; 101(1):122-6. PubMed ID: 18157978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain natriuretic peptide is a good predictor for outcome in cardiac surgery.
    Elíasdóttir SB; Klemenzson G; Torfason B; Valsson F
    Acta Anaesthesiol Scand; 2008 Feb; 52(2):182-7. PubMed ID: 17949462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
    Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-brain natriuretic peptide is a sensitive marker for detecting cardiac metastases in patients with non-small cell lung cancer.
    Lafaras C; Mandala E; Saratzis A; Platogiannis D; Barbetakis N; Papoti S; Christopoulou M; Ilonidis G; Bischiniotis T
    Onkologie; 2009 Jul; 32(7):389-92. PubMed ID: 19556815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of elevated NT-pro-BNP in cardiovascular patients without acute heart failure.
    Pfister R; Tan D; Thekkanal J; Hellmich M; Schneider CA
    Int J Cardiol; 2009 Jan; 131(2):277-80. PubMed ID: 17913264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-type natriuretic peptides for the evaluation of exercise intolerance.
    Mueller C; Maeder MT; Christ A; Reichlin T; Staub D; Noveanu M; Breidthardt T; Potocki M; Brutsche MH
    Am J Med; 2009 Mar; 122(3):265-72. PubMed ID: 19272488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of natriuretic peptide testing for long-term risk assessment following acute ischemic stroke.
    Jensen JK; Atar D; Kristensen SR; Mickley H; Januzzi JL
    Am J Cardiol; 2009 Jul; 104(2):287-91. PubMed ID: 19576362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
    Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NT-pro-BNP predicts worsening renal function in patients with chronic systolic heart failure.
    Pfister R; Müller-Ehmsen J; Hagemeister J; Hellmich M; Erdmann E; Schneider CA
    Intern Med J; 2011 Jun; 41(6):467-72. PubMed ID: 20214692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency department.
    Siebert U; Januzzi JL; Beinfeld MT; Cameron R; Gazelle GS
    Am J Cardiol; 2006 Sep; 98(6):800-5. PubMed ID: 16950189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
    Jarai R; Fellner B; Haoula D; Jordanova N; Heinz G; Karth GD; Huber K; Geppert A
    Crit Care Med; 2009 Jun; 37(6):1837-44. PubMed ID: 19384228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.